Friday, 21 September 2018
First ever international conference on Medicine Quality and Public Health starts soon in Oxford
The Infectious Diseases Data Observatory (IDDO), together with many partners including the United States Pharmacopeia (USP), the Concept Foundation, the Mahidol Oxford Tropical Medicine Research Unit (MORU) and the Wellcome Trust will host the first Medicine Quality and Public Health conference at K...
Friday, 3 August 2018
Applications Open for Global Health Journalism Fellowship
The 2018 Global Health Journalism Fellowship will invite outstanding young journalists to participate in the first ever international conference on Medicine Quality and Public Health at the University of Oxford. Application deadline is 12 August 2018
Monday, 23 July 2018
DFID announces support for triple ACT trials in Asia and Africa
The UK’s Department for International Development (DFID) recently announced that it will commit £9.2 million (USD 13.15 million) of funding to support a new malaria research programme lead by the Mahidol-Oxford Research Unit (MORU). The programme entitled ‘Development of Triple Artemisinin Combinati...
Monday, 23 July 2018
Have you seen the updated WWARN toolkit?
Have you heard of the Malaria Clinical Trials Toolkit? The ‘toolkit’ aims to improve the quality and standard of trial data by creating a step-by-step guide for researchers and clinicians on how to design, implement and analyse malaria clinical trials.
Tuesday, 17 July 2018
WWARN pays tribute to Prof Ogobara Doumbo
The WWARN network is very saddened by the news of the passing of Prof Ogobara Doumbo on Saturday 9 June in Marseille, France. Prof Doumbo was a long-standing WWARN partner and highly respected for his contribution to the malaria community through co-founding the Centre for Malaria Research & Trainin...
Monday, 2 July 2018
Spotlight on P. vivax at the First Malaria World Congress
WWARN’s Clinical Group led by Professor Ric Price joined government ministers, international institutes, malaria experts and civil society organisations in Melbourne Australia for the First Malaria World Congress 1-5 July 2018. Discussions focussed on elimination efforts, cross-sectoral collaboratio...
Tuesday, 12 June 2018
Small children and pregnant women may be underdosed with widely used antimalarial drug
Current recommended treatment regimens for the most widely used medicine for uncomplicated Plasmodium falciparum malaria may be sub-optimal for small children and pregnant women according to a study led by Prof. Joel Tarning, Head of Pharmacometrics at the WorldWide Antimalarial Resistance Network (...
Friday, 11 May 2018
Researchers develop an age-based regimen for single low-dose primaquine to block transmission of malaria in sub-Saharan Africa
The World Health Organization (WHO) recommended in 2012 to add single low-dose primaquine (SLDPQ) to standard artemisinin based combination treatments (ACTs) to block the transmission of Plasmodium falciparum malaria. The target dose of 0.25 mg base/kg body weight (15 mg in a 60 kg adult) was consid...
Wednesday, 25 April 2018
Commonwealth leaders urged to halve malaria cases within five years
The Commonwealth Malaria Summit last week in London (part of CHOGM 2018) welcomed Bill Gates and 12 Heads of State, 2 Deputy Heads of State and many international organisations on Wednesday 18th April. This fantastic event resulted in more than £2.9bn / $4.1bn pledged from Governments, the private s...
Friday, 23 February 2018
Oxford University to host 2018 Quality of Medical Products and Public Health short course
The fourth Quality of Medical Products and Public Health course will take place in Oxford this year, from 17-21 September, at Wolfson College. This multidisciplinary course is aimed at professionals who are interested in the quality of medical products. The application deadline is 18 May.
Wednesday, 29 November 2017
1 in 10 medical products in developing countries is substandard or falsified
Two new WHO publications highlight the prevalence and impact of substandard and falsified medical products. An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from the World Health Organization (WHO).